Better Therapeutics Inc. (BTTX)
0.00
-0.00 (-100.00%)
At close: Mar 11, 2025, 2:09 PM
-100.00% (1D)
| Bid | n/a |
| Market Cap | 10.9K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -92.01M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 255 |
| Avg. Volume (20D) | 20,173 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.10 |
| Beta | 1.69 |
About BTTX
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 17, 2021
Employees 54
Stock Exchange NASDAQ
Ticker Symbol BTTX
Website https://www.bettertx.com
